Determining a risk-proportionate approach to the validation of statistical programming for clinical trials

Author:

Gamble Carrol1,Lewis Steff2,Stocken Deborah3,Juszczak Edmund4,Bradburn Mike5,Doré Caroline6,Kean Sharon17ORCID

Affiliation:

1. Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK

2. Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK

3. Clinical Trials Research Unit, University of Leeds, Leeds, UK

4. Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK

5. Clinical Trials Research Unit, ScHARR, University of Sheffield, Sheffield, UK

6. Comprehensive Clinical Trials Unit, University College London, London, UK

7. Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK

Abstract

Background The contribution of the statistician to the design and analysis of a clinical trial is acknowledged as essential. Ability to reconstruct the statistical contribution to a trial requires rigorous and transparent documentation as evidenced by the reproducibility of results. The process of validating statistical programmes is a key requirement. While guidance relating to software development and life cycle methodologies details steps for validation by information systems developers, there is no guidance applicable to programmes written by statisticians. We aimed to develop a risk-based approach to the validation of statistical programming that would support scientific integrity and efficient resource use within clinical trials units. Methods The project was embedded within the Information Systems Operational Group and the Statistics Operational Group of the UK Clinical Research Collaboration Registered Clinical Trials Unit network. Members were asked to share materials relevant to validation of statistical programming. A review of the published literature, regulatory guidance and knowledge of relevant working groups was undertaken. Surveys targeting the Information Systems Operational Group and Statistics Operational Group were developed to determine current practices across the Registered Clinical Trials Unit network. A risk-based approach was drafted and used as a basis for a workshop with representation from statisticians, information systems developers and quality assurance managers (n = 15). The approach was subsequently modified and presented at a second, larger scale workshop (n = 47) to gain a wider perspective, with discussion of content and implications for delivery. The approach was revised based on the discussions and suggestions made. The workshop was attended by a member of the Medicines for Healthcare products Regulatory Agency Inspectorate who also provided comments on the revised draft. Results Types of statistical programming were identified and categorised into six areas: generation of randomisation lists; programmes to explore/understand the data; data cleaning, including complex checks; derivations including data transformations; data monitoring; or interim and final analysis. The risk-based approach considers each category of statistical programme against the impact of an error and its likelihood, whether the programming can be fully prespecified, the need for repeated use and the need for reproducibility. Approaches to the validation of programming within each category are proposed. Conclusion We have developed a risk-based approach to the validation of statistical programming. It endeavours to facilitate the implementation of targeted quality assurance measures while making efficient use of limited resources.

Publisher

SAGE Publications

Subject

Pharmacology,General Medicine

Reference31 articles.

1. International Conference on Harmonisation. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2), 2016, https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf

2. International Conference on Harmonisation. E9 statistical principles for clinical trials, 1998, https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e9-statistical-principles-clinical-trials

3. Xiong X, Cribben I. The state of play of reproducibility in Statistics: an empirical analysis, 2022, https://arxiv.org/pdf/2209.15602.pdf

4. Good clinical practice inspection metrics, https://www.gov.uk/government/statistics/good-clinical-practice-inspection-metrics-2007-to-present (accessed 4 February 2022).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3